Role of Imaging Tools for the Diagnosis of Borderline Ovarian Tumors: A Systematic Review and Meta-Analysis

Imagem de Miniatura
Citações na Scopus
Tipo de produção
Data de publicação
Título da Revista
ISSN da Revista
Título do Volume
MATTOS, Leandro Accardo de
GONCALVES, Manoel Orlando
KHO, Rosanne M.
Projetos de Pesquisa
Unidades Organizacionais
Borderline ovarian tumors (BOTs) have a low malignant potential and occur most often in young women. Its preoperative diagnosis can improve surgical strategy and reproductive approach. This study systematically reviews the literature for the accuracy of transvaginal ultrasound (TVUS), magnetic resonance (MRI), and computed tomography (CT) in the diagnostic of BOTs. We conducted a search in PubMed/Medline of articles in English from the last 5 years and included 14 studies for systematic review, 9 of them in the meta-analysis. The pooled sensibility and specificity was respectively 77.0% and 83.0% for TVUS (5 studies) and 85% and 74% for MRI (4 studies) in differentiating benign from malignant BOTs. CT and positron emission tomography (PET)-CT techniques were heterogeneous between studies, so a meta-analysis was not performed for the 4 studies on CT and PET-CT. However, these 4 studies have also shown a high accuracy in differentiating BOTs from malignant ovarian cancers.
Borderline ovarian tumors, Computed tomography, Diagnosis, MRI, PET-CT, Ultrasound
  1. Anthoulakis C, 2014, GYNECOL ONCOL, V132, P661, DOI 10.1016/j.ygyno.2013.10.022
  2. Araujo K. G., 2016, ULTRASOUND OBSTET GY
  3. Bakir B, 2011, BRIT J RADIOL, V84, P600, DOI 10.1259/bjr/90706205
  4. Barroilhet L, 2013, J CLIN ULTRASOUND, V41, P269, DOI 10.1002/jcu.22014
  5. Bernardin L, 2012, EUR RADIOL, V22, P880, DOI 10.1007/s00330-011-2331-z
  6. Geza A, 2005, AM J CLIN PATHOL S, V123, pS13
  7. Goyal M, 2016, J CLIN DIAGN RES, V10, pTC1, DOI 10.7860/JCDR/2016/20619.8446
  8. Grabowska-Derlatka L, 2013, INT J GYNECOL CANCER, V23, P1597, DOI 10.1097/IGC.0b013e3182a80a41
  9. GRANBERG S, 1989, GYNECOL ONCOL, V35, P139, DOI 10.1016/0090-8258(89)90031-0
  10. HEILBRUNN KS, 1994, AM J ROENTGENOL, V162, P593
  11. Huchon C, 2012, J OBSTET GYNAECOL RE, V38, P832, DOI 10.1111/j.1447-0756.2011.01785.x
  12. JACOBS I, 1990, BRIT J OBSTET GYNAEC, V97, P922, DOI 10.1111/j.1471-0528.1990.tb02448.x
  13. Janne K, 1993, CANCER, V71, P1810
  14. Kim Chulhan, 2013, Nuclear Medicine and Molecular Imaging, V47, P81, DOI 10.1007/s13139-013-0197-5
  15. KRIGMAN H, 1994, CLIN OBSTET GYNECOL, V37, P475, DOI 10.1097/00003081-199406000-00021
  16. le-Ming S, 2004, AM J PATHOL, V164, P1511
  17. Lil V, 2006, GYNECOL ONCOL, V102, P41
  18. Mansour SM, 2015, BRIT J RADIOL, V88, DOI 10.1259/bjr.20150099
  19. Mascilini F, 2016, ULTRASOUND OBSTET GY
  20. Meys EMJ, 2016, EUR J CANCER, V58, P17, DOI 10.1016/j.ejca.2016.01.007
  21. Moher David, 2009, Open Med, V3, pe123
  22. Montagnana M, 2011, CLIN CHEM LAB MED, V49, P521, DOI 10.1515/CCLM.2011.075
  23. Moro F, 2016, ULTRASOUND OBSTET GY
  24. Outwater EK, 1997, JMRI-J MAGN RESON IM, V7, P689, DOI 10.1002/jmri.1880070414
  25. Palomba S, 2007, HUM REPROD, V22, P578, DOI 10.1093/humrep/del381
  26. Ruiz M, 2016, EUR J OBSTET GYN R B, V205, P115, DOI 10.1016/j.ejogrb.2016.07.493
  27. Sayasneh A, 2015, INT J ONCOL, V46, P445, DOI 10.3892/ijo.2014.2764
  28. Shetty MK, 2015, SEMIN ULTRASOUND CT, V36, P369, DOI 10.1053/j.sult.2015.05.006
  29. Swanton A, 2007, EUR J OBSTET GYN R B, V135, P3, DOI 10.1016/j.ejogrb.2007.05.011
  30. Tajima A, 2016, J MED ULTRASON, V43, P249, DOI 10.1007/s10396-015-0689-2
  31. Tanizaki Y, 2014, INT J GYNECOL CANCER, V24, P454, DOI 10.1097/IGC.0000000000000074
  32. Thomassin-Naggara I, 2013, RADIOLOGY, V267, P432, DOI 10.1148/radiol.13121161
  33. Thomassin-Naggara I, 2012, EUR RADIOL, V22, P738, DOI 10.1007/s00330-011-2329-6
  34. Timmerman D, 2008, ULTRASOUND OBST GYN, V31, P681, DOI 10.1002/uog.5365
  35. Timmerman D, 2000, ULTRASOUND OBST GYN, V16, P500, DOI 10.1046/j.1469-0705.2000.00287.x
  36. TRIMBLE CL, 1994, GYNECOL ONCOL, V55, pS52, DOI 10.1006/gyno.1994.1342
  37. Tsuboyama T, 2014, INVEST RADIOL, V49, P524, DOI 10.1097/RLI.0000000000000050
  38. Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25
  39. Yanaranop M, 2017, GYNECOL OBSTET INVES, V82, P47, DOI 10.1159/000446238
  40. Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31
  41. Zhang P, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-237
  42. Zhao SH, 2014, EUR RADIOL, V24, P2292, DOI 10.1007/s00330-014-3236-4